leadf
logo-loader
view4D pharma PLC

4D pharma joins Hollywood legend Michael J Fox's Parkinson's initiative

Back to the Future actor Michael J Fox was diagnosed with Parkinson’s in 1991 at the age of 29

4D pharma PLC -

4D pharma PLC (LON:DDDD) has joined the initiative to find a cure for Parkinson’s disease being sponsored by Hollywood legend Michael J Fox.

In a statement, 4D pharma said its representatives will join the Parkinson's Progression Markers Initiative (PPMI) Scientific Advisory Board and be closely involved in the design and execution of the study.

“The Michael J Fox Foundation has made considerable contributions to the development of therapeutic solutions for the millions of people with Parkinson's disease," said Alex Stevenson, 4D pharma’s chief scientific officer in a statement.

“Joining the PPMI Scientific Advisory Board will enable 4D pharma to bring its leading expertise in Live Biotherapeutics and the gut-brain axis to the pioneering joint effort that is the PPMI," he added.

PPMI was launched by the Michael J Fox Foundation in 2010 to collect and analyse a suite of clinical, imaging and biological data over time to measure and track disease risk, onset and progression and to establish new biomarkers for use in clinical trials of disease-modifying therapies. 

“4D pharma will play an important role as PPMI considers the microbiome as an area of focus, following a growing body of evidence pointing to the gut microbiome as a new frontier in our understanding and treatment of Parkinson's disease," Stevenson added.

Michael J Fox was diagnosed with Parkinson’s in 1991 at the age of 29.

Quick facts: 4D pharma PLC

Price: 136 GBX

LSE:DDDD
Market: LSE
Market Cap: £178.84 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of 4D pharma PLC named herein, including the promotion by the Company of 4D pharma PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read